Mitochondria in sarcoma and carcinoma: Achilles' heel or Hercules' strength?
Mitochondria emerge as a vulnerable target in sarcomas, suggesting new drug strategies and combination approaches for these aggressive cancers.
This review comprehensively covers the role of mitochondria across sarcoma and carcinoma biology, including metabolic adaptation, programmed cell death regulation, cancer stem cell maintenance, and tumor microenvironment interactions. Sarcoma cells are proposed as particularly susceptible to mitochondrial-targeted therapies, with implications for combination immunotherapy.
What the study was
- Study design
- Comprehensive review
- Population
- Sarcoma and carcinoma patients/preclinical models
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Seminars in Cancer Biology
Why it surfaced
Relevant mitochondria-sarcoma review in top cancer journal; sarcomas have high unmet need but review level — STANDARD at threshold.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.